Literature DB >> 21460197

Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases.

Luis A Martinez-Lemus1, Guiling Zhao, Edgar L Galiñanes, Matthew Boone.   

Abstract

Inward eutrophic remodeling is the most prevalent structural change of resistance arteries in hypertension. Sympathetic and angiotensin (ANG)-induced vasoconstriction has been associated with hypertension and with the production of matrix metalloproteinases (MMPs) and ROS. Therefore, we hypothesize that prolonged exposure to norepinephrine (NE) and ANG II induces arteriolar inward remodeling dependent on the activation of MMPs and the production of ROS. This hypothesis was tested on rat cremaster arterioles that were isolated, cannulated, pressurized, and exposed to either NE (10(-5.5) mol/l) + ANG II (10(-7) mol/l) or vehicle (control) for 4 h. The prolonged exposure to NE + ANG II induced inward remodeling, as evidenced by the reduced maximal arteriolar passive diameter observed after versus before exposure to the vasoconstrictor agonists. NE + ANG II also increased the arteriolar expression and activity of MMP-2 and the production of ROS as determined, respectively, by real-time RT-PCR, gel and in situ zymography, and the use of ROS-sensitive dyes with multiphoton microscopy. Inhibition of MMP activation (with GM-6001) or ROS production (with apocynin or tempol) prevented the NE + ANG II-induced inward remodeling. Inhibition of ROS production prevented the activation of MMPs and the remodeling process, whereas inhibition of MMP activation did not affect ROS production. These results indicate that prolonged stimulation of resistance arterioles with NE + ANG II induces a ROS-dependent activation of MMPs necessary for the development of arteriolar inward remodeling. These mechanisms may contribute to the structural narrowing of resistance vessels in hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460197      PMCID: PMC3119084          DOI: 10.1152/ajpheart.01066.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  56 in total

1.  Prognostic significance of small-artery structure in hypertension.

Authors:  Damiano Rizzoni; Enzo Porteri; Gianluca E M Boari; Carolina De Ciuceis; Intissar Sleiman; Maria Lorenza Muiesan; Maurizio Castellano; Marco Miclini; Enrico Agabiti-Rosei
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

2.  Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways.

Authors:  R M Touyz; E L Schiffrin
Journal:  J Hypertens       Date:  2001-07       Impact factor: 4.844

Review 3.  Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey.

Authors:  K L Christensen; M J Mulvany
Journal:  J Hypertens       Date:  2001-06       Impact factor: 4.844

4.  Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway.

Authors:  Li Hao; Min Du; Ana Lopez-Campistrous; Carlos Fernandez-Patron
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

5.  Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species.

Authors:  Tina Bleeke; Hua Zhang; Nageswara Madamanchi; Cam Patterson; James E Faber
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

6.  Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia.

Authors:  Dae-Il Chang; Naohisa Hosomi; Jacinta Lucero; Ji-Hoe Heo; Takeo Abumiya; Andrew P Mazar; Gregory J del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2003-12       Impact factor: 6.200

Review 7.  Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium.

Authors:  Deborah A Siwik; Wilson S Colucci
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

8.  Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species.

Authors:  Karsten Grote; Inna Flach; Maren Luchtefeld; Elvan Akin; Steven M Holland; Helmut Drexler; Bernhard Schieffer
Journal:  Circ Res       Date:  2003-05-15       Impact factor: 17.367

9.  Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling.

Authors:  Stéphanie Lehoux; Catherine A Lemarié; Bruno Esposito; H Roger Lijnen; Alain Tedgui
Journal:  Circulation       Date:  2004-02-16       Impact factor: 29.690

10.  Significance of matrix metalloproteinases in norepinephrine-induced remodelling of rat hearts.

Authors:  Wilfried Briest; Alexander Hölzl; Beate Rassler; Alexander Deten; Hideo A Baba; Heinz-Gerd Zimmer
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

View more
  34 in total

1.  SAH-induced MMP activation and K V current suppression is mediated via both ROS-dependent and ROS-independent mechanisms.

Authors:  Masayo Koide; George C Wellman
Journal:  Acta Neurochir Suppl       Date:  2015

2.  LIMK (LIM Kinase) Inhibition Prevents Vasoconstriction- and Hypertension-Induced Arterial Stiffening and Remodeling.

Authors:  Mariana Morales-Quinones; Francisco I Ramirez-Perez; Christopher A Foote; Thaysa Ghiarone; Larissa Ferreira-Santos; Maria Bloksgaard; Nicole Spencer; Eric T Kimchi; Camila Manrique-Acevedo; Jaume Padilla; Luis A Martinez-Lemus
Journal:  Hypertension       Date:  2020-06-29       Impact factor: 10.190

3.  [Molecular mechanisms of exercise-induced cardiovascular adaptations. Influence of epigenetics, mechanotransduction and free radicals].

Authors:  W Bloch; F Suhr; P Zimmer
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

4.  Metabolic syndrome impairs reactivity and wall mechanics of cerebral resistance arteries in obese Zucker rats.

Authors:  Steven D Brooks; Evan DeVallance; Alexandre C d'Audiffret; Stephanie J Frisbee; Lawrence E Tabone; Carl D Shrader; Jefferson C Frisbee; Paul D Chantler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

Review 5.  Perturbations of the cerebrovascular matrisome: A convergent mechanism in small vessel disease of the brain?

Authors:  Anne Joutel; Iman Haddad; Julien Ratelade; Mark T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

6.  Uncovering novel roles for matrix metalloproteinases in preeclampsia.

Authors:  Christopher A Foote; Luis A Martinez-Lemus
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-14       Impact factor: 4.733

7.  Absence of Endothelial ERα Results in Arterial Remodeling and Decreased Stiffness in Western Diet-Fed Male Mice.

Authors:  Camila Manrique-Acevedo; Francisco I Ramirez-Perez; Jaume Padilla; Victoria J Vieira-Potter; Annayya R Aroor; Brady J Barron; Dongqing Chen; Dominic Haertling; Cory Declue; James R Sowers; Luis A Martinez-Lemus
Journal:  Endocrinology       Date:  2017-06-01       Impact factor: 4.736

Review 8.  The effects of hypertension on the cerebral circulation.

Authors:  Paulo W Pires; Carla M Dams Ramos; Nusrat Matin; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

9.  Mechanical ventilation reduces rat diaphragm blood flow and impairs oxygen delivery and uptake.

Authors:  Robert T Davis; Christian S Bruells; John N Stabley; Danielle J McCullough; Scott K Powers; Bradley J Behnke
Journal:  Crit Care Med       Date:  2012-10       Impact factor: 7.598

Review 10.  The role of oxidative stress in cerebral aneurysm formation and rupture.

Authors:  Robert M Starke; Nohra Chalouhi; Muhammad S Ali; Pascal M Jabbour; Stavropoula I Tjoumakaris; L Fernando Gonzalez; Robert H Rosenwasser; Walter J Koch; Aaron S Dumont
Journal:  Curr Neurovasc Res       Date:  2013-08       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.